Piramal Pharma
PPLPHARMA.NS
#3002
Rank
HK$31.99 B
Marketcap
HK$24.24
Share price
1.57%
Change (1 day)
104.62%
Change (1 year)

Revenue for Piramal Pharma (PPLPHARMA.NS)

Revenue in 2024 (TTM): HK$8.08 Billion

According to Piramal Pharma's latest financial reports the company's current revenue (TTM ) is HK$8.04 Billion. In 2023 the company made a revenue of HK$7.30 Billion an increase over the revenue in the year 2022 that were of HK$3.24 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Piramal Pharma from 2022 to 2024

2023$4B$5B$6B$7B$8B$9Bcompaniesmarketcap.com

Annual revenue

Year Revenue Change
2024 (TTM) HK$8.08 B10.59%
2023 HK$7.30 B125.34%
2022 HK$3.24 B